Zhongmou Therapeutics
Clinical trials sponsored by Zhongmou Therapeutics, explained in plain language.
-
Experimental eye injection aims to slow vision loss in rare disease
Disease control Recruiting nowThis early-stage trial tests the safety of a new drug called ZM-02, given as an injection into one eye, in 12 adults with retinitis pigmentosa—a genetic condition that causes gradual vision loss. The main goal is to check for side effects, not to cure the disease. Researchers wil…
Phase: EARLY_PHASE1 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New color vision test could help people with severe vision loss
Knowledge-focused Recruiting nowThis study looks at how color vision changes over time in people with inherited retinal diseases (IRDs). Researchers will study 200 participants, including those with IRDs and healthy volunteers, to see how color vision loss relates to changes in the retina's structure. They are …
Sponsor: Zhongmou Therapeutics • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:26 UTC